skip to content
  1. Home
  2. >
  3. Blog

5i Research Blog

Knight Makes a 'GUD' Acquisition

Knight Therapeutics has been a name that has tested investors' patience. While its no debt and high cash offer plenty of protection to the downside, the company does not pay a dividend and investors have been waiting for the company to spend its high cash balance to promote some sort of growth. At last, it seems like the company is finally its that cash to use in what looks like quite a transformative acquisition. What does this mean for how we view and value the company? 

Moez Dec 16, 2019
Headline image for 5 from 5i

5 from 5i

Weekly stock market update & five stock related articles we thought were a must-read this week

Barkha Dec 06, 2019
CMS Buy Now